Related Experiment Video
Updated: Jan 7, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
A Model for the Diversity Explosion Fundamental to Metastasis
1Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, United States.
Cancer metastasis diversity may arise from cytokinesis failure in human pancreas cancer cells. This process generates varied cell sizes and chromosome numbers, potentially explaining tumor adaptability and therapeutic resistance.
Area of Science:
- Oncology
- Cell Biology
- Genetics
Background:
- Metastatic cancer, the primary cause of cancer-related deaths, exhibits extreme adaptability and therapeutic resistance.
- Current models like epithelial-to-mesenchymal transition (EMT) do not fully explain the generation of trait diversity in metastases.
- Understanding the mechanisms driving metastatic diversity is crucial for developing effective cancer therapies.
Purpose of the Study:
- To investigate the mechanisms generating cellular diversity in cancer cells.
- To explore the role of activin-like kinase 4 (ALK4) gene knockout in Panc1 human pancreas cancer cells.
- To identify potential novel pathways contributing to metastatic potential.
Main Methods:
- CRISPR knockout of the ALK4 gene in Panc1 human pancreas cancer cells.
- Time-lapse and fluorescence microscopy to observe cell morphology and behavior.
- FACS analysis and mitotic chromosome squashes to assess cell size, ploidy, and chromosome number.
- Observation of cell division, multinucleation, and cell fusion events.
Main Results:
- ALK4 knockout induced significant morphological diversity in Panc1 cells.
- Cells exhibited variations in size, behavior, and chromosome number, often through cytokinesis failure.
- Generation of large multinuclear cells and smaller, potentially sub-ploid, daughter cells.
- Observed fusion of smaller cells and transfer of genetic material, suggesting a mechanism for genomic diversity.
Conclusions:
- Cytokinesis failure and subsequent cell fusion may be a significant, underappreciated source of genomic diversity in cancer cells.
- This process could bridge the gap between primary tumor mutations and the genomic heterogeneity observed in metastases.
- Findings offer new insights into cancer adaptability and resistance, potentially revealing therapeutic targets.
More Related Videos
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
09:44Generation of Organ-conditioned Media and Applications for Studying Organ-specific Influences on Breast Cancer Metastatic Behavior
Published on: June 13, 2016
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer